Tags
AGI Therapeutics, Alpha Portfolio, Beta Portfolio, Conroy Gold, hedge funds, ISEQ, junior resource stocks, market-neutral, portfolio performance, Prime Active Capital, Siteserv, Smart Alpha Portfolio, Smart Beta Portfolio, TGISVP, Worldspreads
It’s early days yet but, rather serendipitously, I managed to complete the valuation stage of The Great Irish Share Valuation Project by quarter-end. That deserves a performance review, I guess..?!
Let’s first take a look at individual stock performance. btw I mentioned I’ve completed 72 Irish stock valuations, but I’ll continue to include AGI Therapeutics (which was taken over) as a 73rd stock for performance purposes. And remember, Gainers/Losers are based on quarter-end prices vs. the original market prices I noted (as I worked my way through each stock’s valuation in Jan-March). Therefore, this is a TGISVP specific performance snapshot, I’m not attempting a full Q1 stock performance ranking here (though I’d expect they would be pretty similar):